12 Health Care Stocks Moving In Monday's After-Market Session
NovaBridge Biosciences NBP
$1.38
▼ -4.83%
($-0.07)
⚡ High Volume
Open
$1.43
Prev Close
$1.45
Day Range
$1.32 – $1.44
52W Range
$1.43 – $6.79
Market Cap
$168.20M
Beta
1.68
EPS (TTM)
$-0.19
📋 Company Profile
| Industry | Biotechnology |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2020-01-17 |
| Shares Out. | 265,990,000 |
| Website | novabridge.com/ ↗ |
| Phone | 13016702800 |
| Employees | 30 |
About NovaBridge Biosciences
NovaBridge Biosciences operates as a biotechnology platform, combining business development and clinical research to identify and advance pharmaceutical assets. Its inventive immuno-oncology pipeline consists of three clinical stage programs, givastomig; uliledlimab; and ragistomig. Its core product, givastomig, is a potential in-class CLDN18.2 bispecific antibody for the treatment of gastric cancer and other CLDN18.2-positive gastrointestinal malignancies.
NovaBridge Biosciences is a publicly traded company under the ticker symbol NBP on the NASDAQ NMS - GLOBAL MARKET, operating in the Biotechnology industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
8 analysts (2026-09-01)